Alana T Brennan1,2,3, Rachael Bonawitz1,4, Christopher J Gill1, Donald M Thea1, Mary Kleinman1,5, Lawrence Long1,2, Caitryn McCallum1, Matthew P Fox1,2,3. 1. Department of Global Health, Boston University School of Public Health, Boston, MA. 2. Department of Internal Medicine, School of Clinical Medicine, Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 3. Department of Epidemiology, Boston University School of Public Health, Boston, MA. 4. Section of Hospital Medicine, Saint Christopher's Hospital for Children, Philadelphia, PA. 5. Department of Psychology, University of Maryland, College Park, MD.
Abstract
OBJECTIVE: Previous studies have demonstrated that HIV-exposed uninfected (HEU) infants and children experience morbidity and mortality at rates exceeding those of their HIV-unexposed uninfected (HUU) counterparts. We sought to summarize the association between HEU vs. HUU infants and children for the outcomes of diarrhea and pneumonia. DESIGN: Meta-analysis. METHODS: We reviewed studies comparing infants and children in the 2 groups for these infectious disease outcomes, in any setting, from 1993 to 2018 from 6 databases. RESULTS: We included 12 studies, and 17,955 subjects total [n = 5074 (28.3%) HEU and n = 12,881 (71.7%) HUU]. Random-effects models showed HEU infants and children had a 20% increase in the relative risk of acute diarrhea and a 30% increase in the relative risk of pneumonia when compared with their HUU counterparts. When stratifying by time since birth, we showed that HEU vs. HUU children had a 50% and 70% increased risk of diarrhea and pneumonia, respectively, in the first 6 months of life. CONCLUSIONS: We show an increased risk of diarrhea and pneumonia for HEU vs. HUU infants and children. Although we acknowledge, and commend, the immense public health success of prevention of mother-to-child transmission, we now have an enlarging population of children that seem to be vulnerable to not only death, but increased morbidity. We need to turn our attention to understanding the underlying mechanism and designing effective public health solutions. Further longitudinal research is needed to elucidate possible underlying immunological and/or sociological mechanisms that explain these differences in morbidity.
OBJECTIVE: Previous studies have demonstrated that HIV-exposed uninfected (HEU) infants and children experience morbidity and mortality at rates exceeding those of their HIV-unexposed uninfected (HUU) counterparts. We sought to summarize the association between HEU vs. HUU infants and children for the outcomes of diarrhea and pneumonia. DESIGN: Meta-analysis. METHODS: We reviewed studies comparing infants and children in the 2 groups for these infectious disease outcomes, in any setting, from 1993 to 2018 from 6 databases. RESULTS: We included 12 studies, and 17,955 subjects total [n = 5074 (28.3%) HEU and n = 12,881 (71.7%) HUU]. Random-effects models showed HEU infants and children had a 20% increase in the relative risk of acute diarrhea and a 30% increase in the relative risk of pneumonia when compared with their HUU counterparts. When stratifying by time since birth, we showed that HEU vs. HUU children had a 50% and 70% increased risk of diarrhea and pneumonia, respectively, in the first 6 months of life. CONCLUSIONS: We show an increased risk of diarrhea and pneumonia for HEU vs. HUU infants and children. Although we acknowledge, and commend, the immense public health success of prevention of mother-to-child transmission, we now have an enlarging population of children that seem to be vulnerable to not only death, but increased morbidity. We need to turn our attention to understanding the underlying mechanism and designing effective public health solutions. Further longitudinal research is needed to elucidate possible underlying immunological and/or sociological mechanisms that explain these differences in morbidity.
Authors: M I de Moraes-Pinto; A C Almeida; G Kenj; T E Filgueiras; W Tobias; A M Santos; M M Carneiro-Sampaio; C K Farhat; P J Milligan; P M Johnson; C A Hart Journal: J Infect Dis Date: 1996-05 Impact factor: 5.226
Authors: M I de Moraes-Pinto; F Verhoeff; L Chimsuku; P J Milligan; L Wesumperuma; R L Broadhead; B J Brabin; P M Johnson; C A Hart Journal: Arch Dis Child Fetal Neonatal Ed Date: 1998-11 Impact factor: 5.747
Authors: Nazma Mansoor; Thomas J Scriba; Marwou de Kock; Michele Tameris; Brian Abel; Alana Keyser; Francesca Little; Andreia Soares; Sebastian Gelderbloem; Silvia Mlenjeni; Lea Denation; Anthony Hawkridge; W Henry Boom; Gilla Kaplan; Gregory D Hussey; Willem A Hanekom Journal: J Infect Dis Date: 2009-04-01 Impact factor: 5.226
Authors: D M Thea; M E St Louis; U Atido; K Kanjinga; B Kembo; M Matondo; T Tshiamala; C Kamenga; F Davachi; C Brown Journal: N Engl J Med Date: 1993-12-02 Impact factor: 91.245
Authors: Nigel C Rollins; James Ndirangu; Ruth M Bland; Anna Coutsoudis; Hoosen M Coovadia; Marie-Louise Newell Journal: PLoS One Date: 2013-12-02 Impact factor: 3.240
Authors: Kany-Kany Angelique Luabeya; Nontobeko Mpontshane; Malanie Mackay; Honorine Ward; Inga Elson; Meera Chhagan; Andrew Tomkins; Jan Van den Broeck; Michael L Bennish Journal: PLoS One Date: 2007-06-27 Impact factor: 3.240
Authors: Stanzi M le Roux; Elaine J Abrams; Kirsten A Donald; Kirsty Brittain; Tamsin K Phillips; Allison Zerbe; David M le Roux; Max Kroon; Landon Myer Journal: Lancet Child Adolesc Health Date: 2020-01-10
Authors: Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray Journal: J Immunol Date: 2021-11-24 Impact factor: 5.422
Authors: Amy L Slogrove; Barbara Burmen; Mary Ann Davies; Andrew Edmonds; Elaine J Abrams; Ellen G Chadwick; Tessa Goetghebuer; Lynne M Mofenson; Mary E Paul; Claire Thorne; Paige L Williams; Marissa Vicari; Kathleen M Powis Journal: Clin Infect Dis Date: 2022-08-25 Impact factor: 20.999
Authors: Kim Anderson; Emma Kalk; Hlengiwe P Madlala; Dorothy C Nyemba; Nisha Jacob; Amy Slogrove; Mariette Smith; Max Kroon; Michael C Harrison; Brian S Eley; Andrew Boulle; Landon Myer; Mary-Ann Davies Journal: AIDS Date: 2021-05-01 Impact factor: 4.632
Authors: Lawrence Long; Salome Kuchukhidze; Sophie Pascoe; Brooke E Nichols; Matthew P Fox; Refiloe Cele; Caroline Govathson; Amy N Huber; David Flynn; Sydney Rosen Journal: J Int AIDS Soc Date: 2020-11 Impact factor: 5.396